Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Uno Protect
- Development stage
- Preclinical
- Lead developer
- BEVIMI
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Uno Protect is a patent-pending, daily liquid brain health supplement developed by Bevimi. Formulated as a single 1.7-ounce daily shot, it contains ten clinically studied active ingredients, including phospholipid-forms of omega-3 fatty acids (DHA and EPA sourced from Norwegian herring roe), fat-soluble vitamins (such as vitamin D3 and vitamin K2 MK4), magnesium acetyl taurate, curcumin, quercetin, green tea polyphenols (EGCG), and other lipid-soluble botanicals like Korean red ginseng extract. The supplement is designed to target multiple brain health pathways, including neuroinflammation, energy production, circulation, and cellular protection, to support memory, focus, cognitive resilience, and long-term cognitive longevity. It is entering an IRB-approved, randomized, double-blind, placebo-controlled clinical study to evaluate its effects on cognitive decline and biomarkers such as p-tau217, neurofilament light (NfL), and LL-37.
- Brand names
- Uno Protect
- Other names
- Bevimi Uno ProtectUNOi Protect
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Uno Protect.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Uno Protect.